Tag: Moderna

Moderna Says Its Vaccine for Ages Under 6 Will Be Ready for US Review in June

WASHINGTON—Moderna Inc.’s chief medical officer said on Sunday the company’s vaccine for children under 6 years old will be ready for review by a Food and Drug Administration (FDA) panel when it meets in June. Moderna sought emergency use authorization from the FDA on Thursday. An advisory panel of experts to the U.S. drug regulator…


Capitol Report (April 29): Trump Returns to Social Media

With illegal immigration surging at the southern border, President Joe Biden and Mexico’s president spoke on Friday. What’s their plan? For decades at the southern border, illegal immigrants have mostly originated from Mexico and other Central and South American countries, but now Border Patrol is catching people from countries all over the world—even from countries that…


Moderna Announces Vaccine Production Facility to Be Built in the Montreal Area

Moderna’s new vaccine factory in the Montreal area will be able to produce 100 million doses of mRNA vaccines a year and will help develop top scientific talent in Canada, Prime Minister Justin Trudeau said Friday. Trudeau was alongside Moderna CEO Stéphane Bancel and Quebec Premier François Legault at McGill University to announce that the…


Moderna Seeks Health Canada Approval for COVID-19 Vaccine for Kids Under Six

Health Canada is reviewing the first request to approve a COVID-19 vaccine for very young kids. The Moderna application is for children between the ages of six months and five years old. The company says a trial of 6,700 children determined the vaccine was safe and produced a similar antibody response to the one that…


Capitol Report (April 28): Economy Shrinks 1.4% in First Quarter

The economy is shrinking, according to data. This, coupled with red hot inflation and soaring gas prices, is ramping up pressure on the White House and Congress to act. What are they doing about it? President Joe Biden announces another request for funding for Ukraine. The latest amount stands at about $33 billion for the…


Moderna Seeks Clearance for COVID-19 Vaccine for Young Children

Moderna on April 28 said it has asked the U.S. Food and Drug Administration (FDA) to grant emergency use authorization (EUA) to the company for its COVID-19 vaccine for children as young as 6 months. The EUA submission is for two 25-microgram doses of the shot, mRNA-1273, in children 6 months old to 5 years old….


Poland Refuses to Accept and Pay for New COVID-19 Vaccine Deliveries

Poland is refusing to accept or pay for more deliveries of the COVID-19 vaccine under the European Union’s supply contract, amid dwindling demand. The country’s health minister announced the news in remarks on local television on Tuesday. “At the end of last week, we used the force majeure clause and informed both the European Commission…


Moderna Says Trial Results Suggest New Bivalent Booster Vaccine Better at Protecting Against COVID Variants

Pharmaceutical and biotechnology company Moderna has said preliminary results from its study on a COVID-19 vaccine intended to protect against variants of the virus show that it outperformed its currently authorized booster shot, mRNA-1273. The company announced on April 19 that its first bivalent booster vaccine candidate, mRNA-1273.211—which includes mutations found in the Beta variant of concern—demonstrated…


Facts Matter (April 12): Moderna Recalls 764K Vaccine Doses Due to Contamination, 8 Months After 1.6M Doses Recalled in Japan

In Georgia, the secretary of state has just opened an investigation into over 1,600 non-citizens who attempted to register to vote in Georgia. This criminal referral came after a statewide investigation was conducted and found that over half of Georgia’s counties saw non-citizens who attempted to get access to the ballot box. Meanwhile, Moderna has…


Moderna Recalls 764,900 COVID-19 Vaccine Doses After Contamination Found

The U.S. pharmaceutical and biotechnology company Moderna Inc. on Friday issued a recall in Europe involving 764,900 doses of its COVID-19 vaccine “Spikevax” after contaminants were discovered in a vial. “The lot is being recalled due to a foreign body being found in one vial in the lot manufactured at the company’s contract manufacturing site, ROVI,”…